Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection
Phase of Trial: Phase III
Latest Information Update: 14 Oct 2016
Price : $35 *
At a glance
- Drugs Pelubiprofen (Primary) ; Loxoprofen
- Indications Fever
- Focus Registrational; Therapeutic Use
- Sponsors Daewon Pharmaceutical
- 07 Oct 2016 Status changed from recruiting to completed.
- 29 Mar 2015 Planned primary completion date changed from 1 Jun 2014 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 23 Feb 2014 New trial record